Apollo Endosurgery, Inc. 4/A SEC Filings

Filed On	Filing
10 Mar 2022	Form 4/A: Gutteridge Mike, VP, Int'l Sales and Marketing Received 22,610 shares as a grant or award · Granted 11,611 Stock Option (Right to Buy)
20 Aug 2021	Form 4/A: McKhann Chas, Director Sold 21,156 shares ($174K) · Sold 21,148 shares ($167K) · Sold 21,148 shares ($164K)
20 May 2021	Form 4/A: Pacitti David, Director Sold 18,742 shares ($129K)
30 May 2017	Form 4/A: McClellan William D. Jr., Director Bought 300 shares ($1.86K) · Bought 1,700 shares ($10.8K)
10 Feb 2009	Form 4/A: Pancoast Scott R, Director Bought 25,260 shares ($24K)
16 May 2008	Form 4/A: Sabbadini Roger Allen, Director Granted 80,063 Restricted Stock Unit · Granted 72,437 Restricted Stock Unit
16 May 2008	Form 4/A: Pancoast Scott R, Director Granted 216,563 Restricted Stock Unit · Granted 195,937 Restricted Stock Unit
16 May 2008	Form 4/A: Hansen Genevieve, Vice President, Research Granted 47,250 Restricted Stock Unit · Granted 42,750 Restricted Stock Unit
16 May 2008	Form 4/A: Atkinson Gary J G, Vice Prsident, CFO & Secretary Granted 52,500 Restricted Stock Unit · Granted 47,500 Restricted Stock Unit
14 Dec 2007	Form 4/A: Swortwood Donald, Director Granted 50,000 Stock Options

Comments